Hyperhomocysteinemia and Endothelial Dysfunction

Author(s): Zhong-Jian Cheng, Xiaofeng Yang, Hong Wang

Journal Name: Current Hypertension Reviews

Volume 5 , Issue 2 , 2009

Become EABM
Become Reviewer


Hyperhomocysteinemia (HHcy) is a significant and independent risk factor for cardiovascular diseases. Endothelial dysfunction (ED) is the earliest indicator of atherosclerosis and vascular diseases. We and others have shown that HHcy induced ED in human and in animal models of HHcy induced by either high-methionine load or genetic deficiency. Six mechanisms have been suggested explaining HHcy-induced ED. These include 1) nitric oxide inhibition, 2) prostanoids regulation, 3) endothelium-derived hyperpolarizing factors suppression, 4) angiotensin II receptor-1 activation, 5) endothelin-1 induction, and 6) oxidative stress. The goal of this review is to elaborate these mechanisms and to discuss biological and molecular events related to HHcy-induced ED.

Keywords: Hyperhomocysteinemia, endothelial dysfunction, vascular relaxation/vascular contractile responses

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [158 - 165]
Pages: 8
DOI: 10.2174/157340209788166940
Price: $65

Article Metrics

PDF: 3